| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |